Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971] 1

BJU International

Volumn 108, Issue 11, 2011, Pages 1850-1854

  Trivedi, Daksha ^a   Kirby, Michael ^a   Norman, Felicity ^a   Przybytniak, Izabela ^a   Ali, Shehzad ^b   Wellsted, David M ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

cardiovascular risk; erectile dysfunction; health related quality of life; simvastatin

Indexed keywords

CHOLESTEROL; PLACEBO; SIMVASTATIN;

ADULT; ARTICLE; BEDTIME DOSAGE; BLOOD VESSEL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOTHELIUM; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PENIS ERECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; QUALITY OF LIFE; SIMVASTATIN; TREATMENT OUTCOME;

EID: 81255158345     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10122.x     Document Type: Article

References (34)

1. Feldman HA, Johannes CB, Derby CA, et al,. Erectile Dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38 (Pubitemid 30211093)
2. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U,. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-11 (Pubitemid 32175951)
3. Laumann EO, Paik A, Rosen RC,. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-44 (Pubitemid 29081307)
4. Dunn KM, Croft PR, Hackett GI,. Sexual problems: a study of prevalence and need for health care in the general population. Fam Pract 1998; 15: 519-24 (Pubitemid 29084073)
5. Thompson IM, Tangen CM, Goodman PJ, et al,. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996-3002 (Pubitemid 41817661)
6. Litwin MS, Nied RJ, Dhanani N,. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13: 159-66 (Pubitemid 28128994)
7. Speel TGW, van Langen H, Meuleman EJ,. The risk of coronary heart disease in men with erectile dysfunction. Eur Urol 2003; 44: 366-71 (Pubitemid 37051708)
8. Wilson EC, McKeen ES, Scuffham PA, Brown MC, Wylie K, Hackett G,. The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions. Pharmacoeconomics 2002; 20: 879-89 (Pubitemid 35252839)
9. Hackett G, Kell P, Ralph D, et al,. British Society for Sexual Medicine guidelines on the management of erectile dysfunction 2007. J Sex Med 2008; 5: 1841-65
10. Sullivan ME, Keoghane SR, Miller MAW,. Vascular risk factors and erectile dysfunction. BJU Int 2001; 87: 838-45 (Pubitemid 34204326)
11. Fung MM, Bettencourt R, Barrett-Connor E,. Heart disease risk factors predict erectile dysfunction 25 years later. The Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 1405-11 (Pubitemid 38496346)
12. Tikkanen MJ, Jackson G, Tammela T, et al,. Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention. Int J Clin Pract 2007; 61: 265-8
13. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R,. Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2: 40-50 (Pubitemid 40468190)
14. Walczak MK, Lokhandwala N, Hodge MB, Guay AT,. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19-24 (Pubitemid 36013548)
15. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ,. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179-84 (Pubitemid 38201141)
16. Hodges LD, Kirby M, Solanki J, O'Donnell J, Brodie DA,. The temporal relationship between eretile dysfunction and cardiovascular disease. Int J Clin Pract 2007; 61: 2019-25 (Pubitemid 350077416)
17. Tsunekawa T, Hayashi T, Kano H, et al,. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 2001; 104: 376-9 (Pubitemid 32678263)
18. Saltzman EA, Guay AT, Jacobson J,. Improvement in erectile dysfunction in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255-8
19. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB,. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61 (Pubitemid 24046934)
20. Lue TF,. Erectile dysfunction. N Engl J Med 2000; 342: 1802-13 (Pubitemid 30390241)
21. Jackson G,. Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999; 53: 363-8 (Pubitemid 29373844)
22. Sullivan ME, Thompson CS, Dashwood MR, et al,. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43: 658-65 (Pubitemid 29369264)
23. Montorsi P, Montorsi F, Schulman CC,. Is erectile dysfunction the 'tip of the iceberg' of a systemic vascular disorder? Eur Urol 2003; 44: 352-4 (Pubitemid 37051705)
24. Moore RA,. Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports. BMC Urol 2002; 2: 6
25. Masumoto A, Hirooka Y, Hironaga K, et al,. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Am J Cardiol 2001; 88: 1291-4 (Pubitemid 33132098)
26. Herrmann HC, Levine LA, Macaluso J Jr, et al,. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. J Sex Med 2006; 3: 303-8
27. Yaman O, Akand M, Gursoy A, Erdogan MF, Anafarta K,. The effect of diabetes mellitus treatment and good glycaemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: a pilot study. J Sex Med 2006; 3: 344-8
28. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM,. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile function. Int J Impot Res 1999; 11: 319-26 (Pubitemid 30052683)
29. MacDonough RP, Ewings P, Porter T,. The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. J Urol 2007; 167: 212-7
30. Brooks R, Rabin R, de Charro F, eds. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective: Evidence from the EuroQol BIO MED Research Programme. Rotterdam: Kluwer Academic Publishers, 2003
31. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl. 5): v1-52
32. Wilkinson IB, Hall IR, MacCallum H, et al,. Pulse wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-52 (Pubitemid 34076246)
33. McEniery CM, Wallace S, Mackenzie IS, et al,. Endothelial function is associated with pulse pressure, pulse wave velocity and augmentation index in healthy humans. Hypertension 2006; 48: 602-8 (Pubitemid 44843862)
34. Bower P, Wallace P, Ward E, et al,. Improving recruitment to health research in primary care. Fam Pract 2009; 26: 391-7